The Association of the Pharmaceutical Industry in Norway - LMI Norwegian and foreign pharmaceutical companies selling medicinal products in Norway have their own trade organisation, Legemiddelindustriforeningen (LMI) – The Association of the Pharmaceutical Industry in Norway. LMI is working opposite the authorities, with the image and reputation of the industry, providing services towards the member companies, as well as making case assessments and supplying statistical reports. The association organises courses and training activities, e.g. conducting training courses for medical sales representatives and clinical trial monitors. LMI actively participates in international industry associations for manufacturers of pharmaceutical products.
Merck & Co., Inc. is a global research-driven pharmaceutical company established in 1891.
Merck discovers, develops, manufactures and markets vaccines, consumer health products, animal health products and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. MSD Norway was established in 1970 and holds 160 employees in its branch in Drammen. MSD Norway is very active with clinical trials in Norway in addition to marketing and sales of innovative medicines.
Pfizer is the world's largest pharmaceutical company
We have a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and we have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time, like Alzheimer's disease and cancer.
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company
We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.
Aker BioMarine is an integrated biotechnology company – uniquely positioned to create value from krill harvesting and processing.
Aker BioMarine is an integrated biotechnology company – uniquely positioned to create value krill derived biotech products. The company is supplying biomarine ingredients through an optimized value chain from raw materials to customer.
Boehringer Ingelheim belongs to the group of the 20 most leading pharmaceutical companies in the world.
The headquarter is situated in Ingelheim in Germany. The company operates globaly with more than 142 companies in 50 counties and employs more than 41 500 poeple. The company was established in 1885 and is a family owned pharmaceutical company which emphesize the importance of research and development , productiom and marketing of innovative products of high therapeutic value for animals and humans.
Discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders
Biogen Idec uses cutting edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. We are the world's oldest independent biotechnology company and a Fortune 500 company with more than $4 billion in revenues. Patients worldwide benefit from our products.
Lundbeck is a global pharmaceutical company working with Brain disorders
Lundbeck is a global pharmaceutical company conducting research into developing, manufacturing, marketing, selling and distributing pharmaceuticals for the treatment of disorders of the central nervous system (CNS), including depression, schizophrenia, Alzheimer’s disease, Parkinson’s disease, Huntington's disease, epilepsy and insomnia.
Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide. The company was established in Jerusalem in 1901, and is today a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world.
Tevais aleader inthe treatment of multiplesclerosis (MS). The company marketsdrugs thatcanmodify thedisease courseof MS, and is currently developing new drugs in this field. Teva also has asubstantial investmentin a range ofother therapeuticareas, including Parkinson’s disease and Attention Deficit/Hyperactivity Disorder (ADHD).
Supported by Innovation Norway. Copyright © 2012 NansenNeuroScience. All Rights Reserved. Web support: Sustainovate